Methylxanthines for the treatment of apnea associated with bronchiolitis and anesthesia

Paediatric Anaesthesia

Volumn 14, Issue 7, 2004, Pages 541-550

  McNamara, David G ^a,b   Nixon, Gillian M ^a   Anderson, Brian J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Bronchiolitis; Caffeine; Neonatal apnea; Pharmacokinetics; Theophylline

Indexed keywords

CAFFEINE; METHYLXANTHINE; THEOPHYLLINE;

APNEA; BRONCHIOLITIS; CLINICAL TRIAL; DEATH; DISEASE ASSOCIATION; HEART FAILURE; HUMAN; HYPERGLYCEMIA; METABOLIC ACIDOSIS; MUSCLE HYPERTONIA; NERVOUSNESS; PEDIATRIC ANESTHESIA; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYSTEM; REVIEW; RHABDOMYOLYSIS; SHOCK; SIDE EFFECT; STOMACH DISTENSION; SWEATING; SYSTEMATIC REVIEW; TACHYCARDIA; TREMOR; VIRUS INFECTION;

ANESTHESIA, GENERAL; APNEA; BRONCHIOLITIS; CAFFEINE; CLINICAL TRIALS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; RESPIRATORY SYSTEM AGENTS; THEOPHYLLINE;

EID: 3042844407     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2004.01351.x     Document Type: Review

References (102)

1. NIH. Consensus development summaries. Infantile apnea and home monitoring. National Institutes of Health. Connecticut Med 1987; 51: 45-51.
2. Committee on Fetus and Newborn American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003; 111(4 pt 1): 914-917.
3. Daily WJ, Klaus M, Meyer HB. Apnea in premature infants: monitoring, incidence, heart rate changes, and an effect of environmental temperature. Pediatrics 1969; 43: 510-518.
4. Barrington KJ, Finer NN. Periodic breathing and apnea in preterm infants. Pediatr Res 1990; 27: 118-121.
5. Finer NN, Barrington KJ, Hayes B. Prolonged periodic breathing: significance in sleep studies. Pediatrics 1992; 89: 450-453.
6. Di Fiore JM, Arko MK, Miller MJ et al. Cardiorespiratory events in preterm infants referred for apnea monitoring studies. Pediatrics 2001; 108: 1304-1308.
7. Menon AP, Schefft GL, Thach BT. Frequency and significance of swallowing during prolonged apnea in infants. Am Rev Resp Dis 1984; 130: 969-973.
8. Finer NN, Barrington KJ, Hayes BJ et al. Obstructive, mixed, and central apnea in the neonate: physiologic correlates. J Pediatr 1992; 121: 943-950.
9. Upton CJ, Milner AD, Stokes GM. Upper airway patency during apnoea of prematurity. Arch. Dis. Child. 1992; 67(4 spec): 419-424.
10. Lemaire D, Letourneau P, Dorion D et al. Complete glottic closure during central apnea in lambs. J. Otolaryngol. 1999; 28: 13-19.
11. Ramanathan R, Corwin MJ, Hunt CE et al. Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS. JAMA 2001; 285: 2199-2207.
12. Kurth CD, Spitzer AR, Broennle AM et al. Postoperative apnea in preterm infants. Anesthesiology 1987; 66: 483-488.
13. Cote CJ, Zaslavsky A, Downes JJ, Kurth CD et al. Postoperative apnea in former preterm infants after inguinal herniorrhaphy. A combined analysis. Anesthesiology 1995; 82: 809-822.
14. Hatch D, Fletcher M. Anaesthesia and the ventilatory system in infants and young children. Br. J. Anaesth. 1992; 68: 398-410.
15. Hunt CE, Brouillette RT, Hanson D. Apnea-onset definition significantly affects pneumogram results. Sleep 1988; 11: 286-290.
16. Horemuzova E, Katz-Salamon M, Milerad J. Breathing patterns, oxygen and carbon dioxide levels in sleeping healthy infants during the first nine months after birth. Acta Paediatr. 2000; 89: 1284-1289.
17. Hoppenbrouwers T, Hodgman JE, Arakawa K et al. Transcutaneous oxygen and carbon dioxide during the first half year of life in premature and normal term infants. Pediatr. Res. 1992; 31: 73-79.
18. Stebbens VA, Poets CF, Alexander JR et al. Oxygen saturation and breathing patterns in infancy. 1: full term infants in the second month of life. Arch. Dis. Child. 1991; 66: 569-573.
19. Poets CF, Stebbens VA, Lang JA et al. Arterial oxygen saturation in healthy term neonates. Eur. J. Pediatr. 1996; 155: 219-223.
20. Hunt CE, Corwin MJ, Lister G et al. Longitudinal assessment of hemoglobin oxygen saturation in healthy infants during the first 6 months of age. Collaborative Home Infant Monitoring Evaluation (CHIME) Study Group. J. Pediatr. 1999; 135: 580-586.
21. Loughlin G, Brouillette R, Brooks L. Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society. Am. J. Resp. Crit. Care Med. 1996; 153: 866-878.
22. Hunt CE, Hufford DR, Bourguignon C et al. Home documented monitoring of cardiorespiratory pattern and oxygen saturation in healthy infants. Pediatr. Res. 1996; 39: 216-222.
23. Richards JM, Alexander JR, Shinebourne EA et al. Sequential 22-hour profiles of breathing patterns and heart rate in 110 full-term infants during their first 6 months of life. Pediatrics 1984; 74: 763-777.
24. Glotzbach SF, Baldwin RB, Lederer NE et al. Periodic breathing in preterm infants: incidence and characteristics. Pediatrics 1989; 84: 785-792.
25. Hodgman JE, Gonzalez F, Hoppenbrouwers T et al. Apnea, transient episodes of bradycardia, and periodic breathing in preterm infants. Am. J. Dis. Child. 1990; 144: 54-57.
26. Parkins KJ, Poets CF, O'Brien LM et al. Effect of exposure to 15% oxygen on breathing patterns and oxygen saturation in infants: interventional study. BMJ 1998; 316: 887-891.
27. Church NR, Anas NG, Hall CB et al. Respiratory syncytial virus-related apnea in infants. Demographics and outcome. Am. J. Dis. Child. 1984; 138: 247-250.
28. Gavin R, Anderson B, Percival T. Management of severe bronchiolitis: indications for ventilator support. N. Z. Med. J. 1996; 109: 137-139.
29. Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust. Paediatr. J. 1981; 17: 273-276.
30. Butcher-Puech MC, Henderson-Smart DJ, Holley D et al. Relation between apnoea duration and type and neurological status of preterm infants. Arch. Dis. Child. 1985; 60: 953-958.
31. Dransfield DA, Spitzer AR, Fox WW. Episodic airway obstruction in premature infants. Am. J. Dis. Child. 1983; 137: 441-443.
32. Henderson-Smart DJ, Butcher-Puech MC, Edwards DA. Incidence and mechanism of bradycardia during apnoea in preterm infants. Arch. Dis. Child. 1986; 61: 227-232.
33. Hinkes P. Persistent apnea and bradycardia of prematurity. Perinatol. Neonatol. 1984: 17-25.
34. Southall DP, Richards JM, Rhoden KJ et al. Prolonged apnea and cardiac arrhythmias in infants discharged from neonatal intensive care units: failure to predict an increased risk for sudden infant death syndrome. Pediatrics 1982; 70: 844-851.
35. Rosen CL, Glaze DG, Frost JD Jr. Home monitor follow-up of persistent apnea and bradycardia in preterm infants. Am. J. Dis. Child. 1986; 140: 547-550.
36. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics 1997; 100(3 pt 1): 354-359.
37. Hageman JR, Holmes D, Suchy S et al. Respiratory pattern at hospital discharge in asymptomatic preterm infants. Pediatr. Pulmonol. 1988; 4: 78-83.
38. Poets CF, Stebbens VA, Alexander JR et al. Arterial oxygen saturation in preterm infants at discharge from the hospital and six weeks later. J. Pediatr. 1992; 120: 447-454.
39. Albani M, Bentele KH, Budde C et al. Infant sleep apnea profile: preterm vs term infants. Eur. J. Pediatr. 1985; 143: 261-268.
40. Henderson FW, Clyde WA Jr, Collier AM et al. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J. Pediatr. 1979; 95: 183-190.
41. Hall CB. Respiratory syncytial virus: a continuing culprit and conundrum. J. Pediatr. 1999; 135(2 pt 2): 2-7.
42. Kim HW, Arrobio JO, Brandt CD et al. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am. J. Epidemiol. 1973; 98: 216-225.
43. Lebel MH, Gauthier M, Lacroix J et al. Respiratory failure and mechanical ventilation in severe bronchiolitis. Arch. Dis. Child. 1989; 64: 1431-1437.
44. Outwater KM, Crone RK. Management of respiratory failure in infants with acute viral bronchiolitis. Am. J. Dis. Child. 1984; 138: 1071-1075.
45. Bruhn FW, Mokrohisky ST, McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J. Pediatr. 1977; 90: 382-386.
46. Anas N, Boettrich C, Hall CB et al. The association of apnea and respiratory syncytial virus infection in infants. J. Pediatr. 1982; 101: 65-68.
47. Kneyber MC, Brandenburg AH, de Groot R et al. Risk factors for respiratory syncytial virus associated apnoea. Eur. J. Pediatr. 1998; 157: 331-335.
48. Lindgren C, Lin J, Graham BS et al. Respiratory syncytial virus infection enhances the response to laryngeal chemostimulation and inhibits arousal from sleep in young lambs. Acta Paediatr. 1996; 85: 789-797.
49. Lindgren C, Grogaard J. Reflex apnoea response and inflammatory mediators in infants with respiratory tract infection. Acta Paediatr 1996; 85: 798-803.
50. Nishino T, Hiraga K, Yokokawa N. Laryngeal and respiratory responses to tracheal irritation at different depths of enflurane anesthesia in humans. Anesthesiology 1990; 73: 46-51.
51. Nishino T. Physiological and pathophysiological implications of upper airway reflexes in humans. Jpn J. Physiol. 2000; 50: 3-14.
52. Steward DJ. Preterm infants are more prone to complications following minor surgery than are term infants. Anesthesiology 1982; 56: 304-306.
53. Kurth CD, LeBard SE. Association of postoperative apnea, airway obstruction, and hypoxemia in former premature infants. Anesthesiology 1991; 75: 22-26.
54. Welborn LG, Rice LJ, Hannallah RS et al. Postoperative apnea in former preterm infants: prospective comparison of spinal and general anesthesia. Anesthesiology 1990; 72: 838-842.
55. Krane EJ, Haberkern CM, Jacobson LE. Postoperative apnea, bradycardia, and oxygen desaturation in formerly premature infants: prospective comparison of spinal and general anesthesia. Anesth. Analg. 1995; 80: 7-13.
56. Ochiai R, Guthrie RD, Motoyama EK. Effects of varying concentrations of halothane on the activity of the genioglossus, intercostals, and diaphragm in cats: an electromyographic study. Anesthesiology 1989; 70: 812-816.
57. Hershenson M, Brouillette RT, Olsen E et al. The effect of chloral hydrate on genioglossus and diaphragmatic activity. Pediatr. Res. 1984; 18: 516-519.
58. Brown KA. What we don't know about childhood obstructive sleep apnoea. Paediatr. Anaesth. 2001; 11: 385-389.
59. Isono S, Tanaka A, Ishikawa T et al. Developmental changes in collapsibility of the passive pharynx during infancy. Am. J. Resp. Crit. Care Med. 2000; 162(3 pt 1): 832-836.
60. Boutroy MJ, Vert P, Royer RJ et al. Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. J. Pediatr. 1979; 94: 996-998.
61. Bada HS, Khanna NN, Somani SM et al. Interconversion of theophylline and caffeine in newborn infants. J. Pediatr. 1979; 94: 993-995.
62. Aranda JV, Cook CE, Gorman W et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J. Pediatr. 1979; 94: 663-668.
63. Aranda JV, Turman T. Methylxanthines in apnea of prematurity. Clin. Perinat. 1979; 6: 87-108.
64. Anderson BJ, Gunn TR, Holford NH et al. Caffeine overdose in a premature infant: clinical course and pharmacokinetics. Anaesth. Intensive Care 1999; 27: 307-311.
65. Le Guennec JC, Billon B, Pare C. Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding. Pediatrics 1985; 76: 834-840.
66. Lee TC, Charles B, Steer P et al. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. Clin. Pharmacol. Ther. 1997; 61: 628-640.
67. Anderson BJ, Meakin GH. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr. Anaesth. 2002; 12: 205-219.
68. West JR, Smith HW, Chasis H. Glomerular filtration rate, effective renal blood flow, and maximal tubular excretory capacity in infancy. J. Pediatr. 1948; 32: 10-18.
69. Aldridge A, Aranda JV, Neims AH. Caffeine metabolism in the newborn. Clin. Pharmacol. Ther. 1979; 25: 447-453.
70. Cazeneuve C, Pons G, Rey E et al. Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults. Br. J. Clin. Pharmacol. 1994; 37: 405-412.
71. Anwar M, Mondestin H, Mojica N et al. Effect of caffeine on pneumogram and apnoea of infancy. Arch. Dis. Child. 1986; 61: 891-895.
72. Driscoll MS, Ludden TM, Casto DT et al. Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models. J. Pharmacokinet. Biopharm. 1989; 17: 141-168.
73. Kraus DM, Fischer JH, Reitz SJ et al. Alterations in theophylline metabolism during the first year of life. Clin. Pharmacol. Ther. 1993; 54: 351-359.
74. Grygiel JJ, Birkett DJ. Effect of age on patterns of theophylline metabolism. Clin. Pharmacol. Ther. 1980; 28: 456-462.
75. Tserng KY, King KC, Takieddine FN. Theophylline metabolism in premature infants. Clin. Pharmacol. Ther. 1981; 29: 594-600.
76. Simons FE, Simons KJ. Pharmacokinetics of theophylline in infancy. J. Clin. Pharmacol. 1978; 18: 472-476.
77. Anderson BJ, Holford NH, Woollard GA. Aspects of theophylline clearance in children. Anaesth. Int Care 1997; 25: 497-501.
78. Lesko LJ. Dose-dependent elimination kinetics of theophylline. Clin. Pharmacokinet. 1979; 4: 449-459.
79. Tang Liu DD, Williams RL, Riegelman S. Nonlinear theophylline elimination. Clin. Pharmacol. Ther. 1982; 31: 358-369.
80. Butts JD, Secrest B, Berger R. Nonlinear theophylline pharmacokinetics. A preventable cause of iatrogenic theophylline toxic reactions. Arch. Intern. Med. 1991; 151: 2073-2077.
81. Shann F. Drug Doses, 11th edn. Melbourne: Collective Pry Ltd, 2001.
82. Steer P, Henderson-Smart D. Methylxanthine for treatment of apnea in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
83. Henderson-Smart D, Davis PG. Prophylactic methylxanthine for extubation in preterm infants. (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
84. Henderson-Smart D, Steer PA. Prophylactic methylxanthine for preventing of apnea in preterm infants. (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
85. Steer P, Henderson-Smart D Caffeine vs theophylline for apnea in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
86. Kelly DH, Shannon DC. Treatment of apnea and excessive periodic breathing in the full-term infant. Pediatrics 1981; 68: 183-186.
87. Hunt CE, Brouillette RT, Hanson D. Theophylline improves pneumogram abnormalities in infants at risk for sudden infant death syndrome. J. Pediatr. 1983; 103: 969-974.
88. Finer NN, Peters KL, Duffley LM et al. An evaluation of theophylline for idiopathic apnea of infancy. Dev. Pharmacol. Ther. 1984; 7: 73-81.
89. Paky F, Donath P, Huebmer E et al. Theophylline for infants with abnormal pneumographic results. A randomized double blind, placebo-controlled trial. Klin. Padiatr. 1997; 209: 66-70.
90. Aranda JV, Turmen T, Davis J et al. Effect of caffeine on control of breathing in infantile apnea. J. Pediatr. 1983; 103: 975-978.
91. Tobias JD. Caffeine in the treatment of apnea associated with respiratory syncytial virus infection in neonates and infants. S. Med. J. 2000; 93: 294-296.
92. Welborn LG, Hannallah RS, Fink R et al. High-dose caffeine suppresses postoperative apnea in former preterm infants. Anesthesiology 1989; 71: 347-349.
93. Scanlon JE, Chin KC, Morgan ME et al. Caffeine or theophylline for neonatal apnoea? Arch. Dis. Child. 1992; 67(4 Spec No): 425-428.
94. Peliowski A, Finer NN. A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J. Pediatr. 1990; 116: 648-653.
95. Eyal F, Alpan G, Sagi E et al. Aminophylline vs doxapram in idiopathic apnea of prematurity: a double-blind controlled study. Pediatrics 1985; 75: 709-713.
96. Henderson-Smart D, Steer PA. Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants. (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 2002.
97. LeBard S, Kurth C, Spitzer A et al. Preventing postoperative apnea by neuromodulator antagonists. Anesthesiology 1989; 71: A1026.
98. Welborn L, Soto HD, Hannallah R et al. The use of caffeine in the control of post-anesthetic apnea in former premature infants. Anesthesiology 1988; 68: 796-798.
99. Fisher DM. When is the ex-premature infant no longer at risk for apnea? Anesthesiology 1995; 82: 807-808.
100. Anderson BJ, Ellis JF. Common errors of drug administration in infants: causes and avoidance. Paediatr. Drugs 1999; 1: 93-107.
101. Lonnerholm G, Lindstrom B, Paalzow L et al. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life. Eur. J. Clin. Pharmacol. 1983; 24: 371-374.
102. Goodman LS, Gilman AG, Rail TW et al. The Pharmacological Basis of Therapeutics, 7th edn. New York: MacMillan Publishing Co., 1985.